全文获取类型
收费全文 | 112121篇 |
免费 | 12472篇 |
国内免费 | 7183篇 |
专业分类
耳鼻咽喉 | 1047篇 |
儿科学 | 1396篇 |
妇产科学 | 1692篇 |
基础医学 | 12626篇 |
口腔科学 | 1946篇 |
临床医学 | 14516篇 |
内科学 | 17822篇 |
皮肤病学 | 1452篇 |
神经病学 | 6350篇 |
特种医学 | 3871篇 |
外国民族医学 | 41篇 |
外科学 | 12799篇 |
综合类 | 18278篇 |
现状与发展 | 17篇 |
一般理论 | 12篇 |
预防医学 | 7675篇 |
眼科学 | 3323篇 |
药学 | 11655篇 |
101篇 | |
中国医学 | 5904篇 |
肿瘤学 | 9253篇 |
出版年
2024年 | 471篇 |
2023年 | 2272篇 |
2022年 | 4162篇 |
2021年 | 5303篇 |
2020年 | 4291篇 |
2019年 | 3474篇 |
2018年 | 4183篇 |
2017年 | 3936篇 |
2016年 | 3662篇 |
2015年 | 5213篇 |
2014年 | 6399篇 |
2013年 | 6077篇 |
2012年 | 8486篇 |
2011年 | 8646篇 |
2010年 | 6058篇 |
2009年 | 5070篇 |
2008年 | 6038篇 |
2007年 | 5814篇 |
2006年 | 5523篇 |
2005年 | 5313篇 |
2004年 | 3932篇 |
2003年 | 3758篇 |
2002年 | 3309篇 |
2001年 | 2794篇 |
2000年 | 2691篇 |
1999年 | 2723篇 |
1998年 | 1680篇 |
1997年 | 1707篇 |
1996年 | 1301篇 |
1995年 | 1263篇 |
1994年 | 1017篇 |
1993年 | 653篇 |
1992年 | 748篇 |
1991年 | 673篇 |
1990年 | 582篇 |
1989年 | 499篇 |
1988年 | 398篇 |
1987年 | 392篇 |
1986年 | 292篇 |
1985年 | 236篇 |
1984年 | 147篇 |
1983年 | 108篇 |
1982年 | 80篇 |
1981年 | 68篇 |
1980年 | 43篇 |
1979年 | 49篇 |
1978年 | 21篇 |
1973年 | 19篇 |
1972年 | 18篇 |
1966年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 359 毫秒
991.
Qi-Long Lu Richard Poulsom Leslie Wong Andrew M. Hanby 《The Journal of pathology》1993,169(4):431-437
The B-cell leukaemia/lymphoma-2 (bcl-2) proto-oncogene is unusual as its product appears to provide survival advantage to B cells by blocking apoptosis. In this study, the expression of bcl-2 has been examined in normal nonhaematopoietic tissues, embryos, and psoriatic skin by immunohistochemical staining. Bcl-2 protein expression is mainly observed in cell populations with a long life and/or proliferating ability such as duct cells in exocrine glands, basal keratinocytes, cells at the bottom of colon crypts, and neurons. In the skin of both adult and embryo and also embryonic kidney and cartilage, bcl-2 expression was observed in cells which were undergoing morphological transition from undifferentiated stem cells to committed precursor cells. The finding of bcl-2 expression in the terminal differentiated syncytial trophoblast, but not cytotrophoblast, and in some cells responsive to hormone stimulation such as in the endometrium and myometrium suggests that the gene expression may be related too hormone responsiveness. As no bci-2 localization was seen in the benign hyperproliferative skin condition psoriasis, this does not suggest a straightforward link to proliferation. These observations support the view that the bcl-2 gene may have an important role in cell development, maturation, and the path to terminal differentiation. 相似文献
992.
生物降解性防术后粘连膜的实验研究 总被引:6,自引:0,他引:6
本文首次采用新型医用天然高分子材料壳聚糖作膜材料,制备了可降解吸收防术后粘连膜,并通过动物实验研究其生物降解性和生物相容性.初步研究结果表明,壳聚糖具有很好的成膜性。壳聚糖膜在小鼠体内可以缓慢降解,并具有较好的生物相容性,是一种很有发展前景的天然防术后粘连膜材料。 相似文献
993.
Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus. 总被引:1,自引:0,他引:1
Ming-Chi Lu Ko-Jen Li Song-Chou Hsieh Cheng-Han Wu Chia-Li Yu 《Journal of microbiology, immunology, and infection》2006,39(6):471-475
BACKGROUND AND PURPOSE: Systemic lupus erythematosus (SLE), a prototype of systemic autoimmune disease characterized by multiorgan involvement with diverse clinical and serological manifestations, principally affects women in their child-bearing years. Clinically significant hepatic abnormality as the initial presentation of SLE has rarely been reported. METHODS: Eleven patients with lupus with initial presentation of lupus-related hepatitis were included in this retrospective review. Clinical manifestation, immunological profiles, and risk factors for poor prognosis were analyzed. RESULTS: The most commonly associated clinical manifestations were found to be thrombocytopenia, leukopenia, advancing age, and presence of anti-SSA/Ro antibody and anti-thyroid antibodies. The diagnosis of SLE was delayed due to dominant hepatic abnormalities. Age greater than 50 years and marked hepatic decompensation in accordance with Child classification B and C might suggest poor prognosis (p=0.06). However, the p value was not statistically significant because of the small sample size. CONCLUSIONS: Lupus-related hepatitis, particularly in late-onset lupus, is common. In addition, the presence of anti-SSA, anti-thyroglobulin, and anti-microsomal antibodies is indicative of hepatic involvement in patients with SLE. 相似文献
994.
Z Y Lu J Brochier J Wijdenes H Brailly R Bataille B Klein 《European journal of immunology》1992,22(11):2819-2824
A patient with plasma cell leukemia was treated with anti-interleukin (IL)-6 monoclonal antibodies (mAb) for 2 months. Using chromatography on protein A-Sepharose, anti-murine-IgG-Sepharose, anti-IL-6-mAb-Sepharose and gel filtration at pH 2.3, we have demonstrated that the anti-IL-6 mAb, by preventing the binding of IL-6 to its cell membrane receptor and its renal elimination, has induced huge amounts of IL-6 to circulate in the form of monomeric immune complexes. By using this observation, we have developed a mathematical modelling that allows the determination of the overall daily production of IL-6 in this patient, which was in the range of 15 micrograms per day. Overall in vivo production of cytokines has never been evaluated in animals or in humans before. 相似文献
995.
Yuan-Yuan Zhu Zheng-Bing Zhu-Ge Deng-Chang Wu Shuang Wang Lu-Ying Liu Hiroshi Ohtsu Zhong Chen 《Neuroscience letters》2007
In the present study, we used both histidine decarboxylase-deficient (HDC-KO) mice and wild-type (WT) mice to elucidate the possible role of carnosine in pentylenetetrazol (PTZ)-induced seizures. In the acute PTZ challenge study, PTZ (75 mg/kg) was injected intraperitoneally (i.p.) to induce seizures. Carnosine (200, 500 or 1000 mg/kg, i.p.) significantly decreased seizure stage, and prolonged the latency for myoclonic jerks in WT mice in a dose-dependent manner. The effects of carnosine (500 mg/kg) were time-dependent and reached a peak at 1 h. However, it had no significant effect on HDC-KO mice. Carnosine (500 mg/kg) also significantly elevated the thresholds in WT mice but not HDC-KO mice following intravenous (tail vein) administration of PTZ. We also found that α-fluoromethylhistidine substantially reversed the protective effects of carnosine in WT mice. In addition, carnosine pretreatment reduced the cortical EEG activity induced by PTZ (75 mg/kg, i.p.). These results indicate that carnosine can protect against PTZ-induced seizures and its action is mainly through the carnosine–histidine–histamine metabolic pathway. This suggests that carnosine may be an endogenous anticonvulsant factor in the brain and may be used as a new antiepileptic drug in the future. 相似文献
996.
We report here the molecular cloning of a newly identified preprotachykinin gene, Pptc, which specifies the sequence for a new preprotachykinin protein and bioactive peptide designated hemokinin 1 (HK-1). PPT-C mRNA was detected primarily in hematopoietic cells in contrast to the previously described Ppta and Pptb genes, which are predominantly expressed in neuronal tissues. HK-1 has several biological activities that are similar to the most studied tachykinin, substance P, such as induction of plasma extravasation and mast cell degranulation. However, HK-1 also has properties that are indicative of a critical role in mouse B cell development. HK-1 stimulated the proliferation of interleukin 7-expanded B cell precursors, whereas substance P had no effect. HK-1, but not substance P, promoted the survival of freshly isolated bone marrow B lineage cells or cultured, lipopolysaccharide-stimulated pre-B cells. N-acetyl-L-trytophan-3,5-bistrifluromethyl benzyl ester, a tachykinin receptor antagonist, increased apoptosis of these cells and in vivo administration of this antagonist led to specific reductions of the B220lowCD43 population (the pre-B cell compartment) in the bone marrow and the IgMhighIgDlow population (the newly generated B cells) in the spleen. Thus, HK-1 may be an autocrine factor that is important for the survival of B cell precursors at a critical phase of development. 相似文献
997.
Ren-Wu Chen X.-C. May Lu Changping Yao Zhilin Liao Zhi-Gang Jiang Hans Wei Hossein A. Ghanbari Frank C. Tortella Jitendra R. Dave 《Neuroscience letters》2007
In an earlier study, we demonstrated that PAN-811 (3-aminopyridine-2-carboxaldehyde thiosemicarbazone), a novel neuroprotectant, provides protection against glutamate, staurosporine, veratridine, or hypoxia/hypoglycemia toxicities in primary cortical neuronal cultures by upregulating Bcl-2 expression [R.-W. Chen, C. Yao, X.C. Lu, Z.-G. Jiang, R. Whipple, Z. Liao, H.A. Ghanbari, B. Almassian, F.C. Tortella, J.R. Dave. PAN-811 (3-aminopyridine-2-carboxaldehyde thiosemicarbazone), a novel neuroprotectant, elicits its function in primary neuronal cultures by upregulating Bcl-2 expression. Neuroscience 135 (2005) 191–201]. Both JNK (c-Jun N-terminal kinase) and p38 MAP (mitogen-activated protein) kinase activation have a direct inhibitory action on Bcl-2 by phosphorylation. In the present study, we continued to explore the mechanism of PAN-811 neuroprotection. Our results indicate that treatment of cultured cortical neurons with glutamate (100 μM) induces phosphorylation of both JNK and p38 MAPK. Specifically, pretreatment of neurons with 10 μM PAN-811 (an optimal neuroprotective concentration) for 1 h, 4 h, or 24 h significantly suppresses glutamate-mediated activation of both JNK and p38 MAPK. Furthermore, the p38 MAPK-specific inhibitor SB203580 and the JNK-specific inhibitor SP600125 prevented glutamate-induced neuronal death in these primary cultures. Our results demonstrate that glutamate-induced phosphorylation of JNK and p38 MAPK is suppressed by PAN-811, which might contribute to Bcl-2 upregulation and PAN-811 neuroprotection. 相似文献
998.
Cocaine or delta 9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, has no effect on in vitro cytotoxicity mediated by natural killer (NK) cells and cytotoxic T-lymphocytes (CTL) at concentrations similar to those observed in vivo. 相似文献
999.
Lu HH El-Amin SF Scott KD Laurencin CT 《Journal of biomedical materials research. Part A》2003,64(3):465-474
In the past decade, tissue engineering-based bone grafting has emerged as a viable alternative to biological and synthetic grafts. The biomaterial component is a critical determinant of the ultimate success of the tissue-engineered graft. Because no single existing material possesses all the necessary properties required in an ideal bone graft, our approach has been to develop a three dimensional (3-D), porous composite of polylactide-co-glycolide (PLAGA) and 45S5 bioactive glass (BG) that is biodegradable, bioactive, and suitable as a scaffold for bone tissue engineering (PLAGA-BG composite). The objectives of this study were to examine the mechanical properties of a PLAGA-BG matrix, to evaluate the response of human osteoblast-like cells to the PLAGA-BG composite, and to evaluate the ability of the composite to form a surface calcium phosphate layer in vitro. Structural and mechanical properties of PLAGA-BG were measured, and the formation of a surface calcium phosphate layer was evaluated by surface analysis methods. The growth and differentiation of human osteoblast-like cells on PLAGA-BG were also examined. A hypothesis was that the combination of PLAGA with BG would result in a biocompatible and bioactive composite, capable of supporting osteoblast adhesion, growth and differentiation, with mechanical properties superior to PLAGA alone. The addition of bioactive glass granules to the PLAGA matrix resulted in a structure with higher compressive modulus than PLAGA alone. Moreover, the PLAGA-BA composite was found to be a bioactive material, as it formed surface calcium phosphate deposits in a simulated body fluid (SBF), and in the presence of cells and serum proteins. The composite supported osteoblast-like morphology, stained positively for alkaline phosphatase, and supported higher levels of Type I collagen synthesis than tissue culture polystyrene controls. We have successfully developed a degradable, porous, polymer bioactive glass composite possessing improved mechanical properties and osteointegrative potential compared to degradable polymers of poly(lactic acid-glycolic acid) alone. Future work will focus on the optimization of the composite scaffold for bone tissue-engineering applications and the evaluation of the 3-D composite in an in vivo model. 相似文献
1000.